Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date

Despite declining global malaria incidence, the disease continues to be a threat to people living in endemic regions. In 2015, an estimated 214 million new malaria cases and 438,000 deaths due to malaria were recorded. Plasmodium vivax is the second most common cause of malaria next to Plasmodium fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebstie, Yehenew A, Abay, Solomon M, Tadesse, Wondmagegn T, Ejigu, Dawit A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970641/
https://www.ncbi.nlm.nih.gov/pubmed/27528800
http://dx.doi.org/10.2147/DDDT.S61443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970641/
https://www.ncbi.nlm.nih.gov/pubmed/27528800
http://dx.doi.org/10.2147/DDDT.S61443

Ejemplares similares